Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EUROFINS SCIENTIFIC SE

(ERF)
  Report
Real-time Quote. Real-time Euronext Paris - 05/05 11:35:16 am
82.72 EUR   +0.39%
05/05EUROFINS SCIENTIFIC  : Shares in Issue
PU
05/03EUROFINS SCIENTIFIC SE : Technically solid
04/28Global markets live: Microsoft, Apple, Tesla...
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Eurofins Scientific SE : Technically solid

05/03/2021 | 02:53am EDT
long trade
Live
Entry price : 82.53€ | Target : 88.49€ | Stop-loss : 80.35€ | Potential : 7.22%
Shares in Eurofins Scientific SE do not show any sign of a slowdown in the ascending dynamic. Investors could bet on a continuation of the underlying trend.
Investors have an opportunity to buy the stock and target the € 88.49.
Eurofins Scientific SE : Eurofins Scientific SE : Technically solid
Strengths
  • The group usually releases upbeat results with huge surprise rates.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • The tendency within the weekly time frame is positive above the technical support level at 68.63 EUR

Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at EUR 88.21.
  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • With a 2021 P/E ratio at 29.8 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • The company is not the most generous with respect to shareholders' compensation.
Ratings chart
Subsector Testing Laboratories
1st jan.Capitalization (M$)Investor Rating
EUROFINS SCIENTIFIC SE20.53%18 973
SGS AG2.17%22 306
CENTRE TESTING INTERNATIONA..19.55%8 447
CHINA BUILDING MATERIAL TES..18.35%1 542
SPORTON INTERNATIONAL INC.-5.97%832
SUZHOU ELECTRICAL APPARATUS..-7.52%768
More Results

© MarketScreener.com 2021

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials
Sales 2021 5 928 M 7 115 M 7 115 M
Net income 2021 529 M 635 M 635 M
Net Debt 2021 2 312 M 2 775 M 2 775 M
P/E ratio 2021 29,9x
Yield 2021 0,79%
Capitalization 15 808 M 18 973 M 18 974 M
EV / Sales 2021 3,06x
EV / Sales 2022 3,11x
Nbr of Employees 51 516
Free-Float 66,4%
Upcoming event on EUROFINS SCIENTIFIC SE
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 85,65 €
Last Close Price 82,72 €
Spread / Highest target 20,9%
Spread / Average Target 3,54%
Spread / Lowest Target -31,1%
EPS Revisions
Managers and Directors
NameTitle
Gilles G. Martin Chairman & Chief Executive Officer
Laurent Lebras Director-Group Finance & Administration
Christian Wurst Chief Operating Officer-Food & Environment Testing
Stuart Anderson Independent Non-Executive Director
Féréchté Pouchantchi Independent Non-Executive Director